Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar…

By L. Yatham, Sidney H. Kennedy, S. Parikh, A. Schaffer, S. Beaulieu, M. Alda, C. O’Donovan, Glenda Macqueen, R. McIntyre, Verinder Sharma and 11 more. Bipolar Disorders, 2013

1,300 citations recorded by the source corpus.

Subfields: Psychiatry and Mental health, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/1c672c596525bdd051e1a2ca9468eeef7eb8a6b0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. McIntyre
2. R. Milev
3. Sidney H. Kennedy
4. Darryl L Bassett
5. Glenda Macqueen
6. S. Parikh
7. P. Giacobbe
8. P. Blier

Citations in the corpus

• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018, neutral): “During this time period, CANMAT has strived to translate advances in research to international consensus on evidence based clinical management; first by publishing 2005 guidelines accompanied by expert commentaries, then by providing updates in 2007 (2), 2009 (3) and 2013 (4) in collaboration with t”
• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “Long-acting injectable risperidone and ziprasidone have some support in the prevention of both manic and depressive episodes (Level II) (Yatham et al., 2009), and paliperidone has been trialled in the prevention of mania (Berwaerts et al.”
• Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016, background): “CANMAT, in collaboration with the International Society for Bipolar Disorders, has published separate guidelines for bipolar disorder.(2) This section on ‘‘Pharmacological Treatments’’ is 1 of 6 CANMAT guidelines articles; other sections of the guidelines expand on burden and principles of care, psy”
• Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016, background): “CANMAT, in collaboration with the International Society for Bipolar Disorders, has published separate guidelines for bipolar disorder.(2) This section on ‘‘Neurostimulation Treatments’’ is 1 of 6 guidelines articles; other sections of the guidelines will expand on disease burden and principles of ca”